JPMorgan Chase & Co’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.8K | Sell |
|
|||||
|
2025
Q1 | $105K | Sell |
|
|||||
|
2024
Q4 | $277K | Buy |
|
|||||
|
2024
Q3 | $134K | Sell |
|
|||||
|
2024
Q2 | $141K | Sell |
|
|||||
|
2024
Q1 | $1.46M | Buy |
|
|||||
|
2023
Q4 | $315K | Sell |
|
|||||
|
2023
Q3 | $374K | Buy |
|
|||||
|
2023
Q2 | $748K | Sell |
|
|||||
|
2023
Q1 | $1.48M | Buy |
|
|||||
|
2022
Q4 | $1.99M | Buy |
|
|||||
|
2022
Q3 | $3.81M | Sell |
|
|||||
|
2022
Q2 | $3.44M | Buy |
|
|||||
|
2022
Q1 | $2.62M | Buy |
|
|||||
|
2021
Q4 | $3.59M | Buy |
|
|||||
|
2021
Q3 | $5.06M | Buy |
|